Advertisement

Topics

EKOS Corporation Company Profile

20:21 EST 16th February 2019 | BioPortfolio

EKOS Corporation pioneered the development and clinical application of ultrasonic accelerated drug delivery in medicine, introducing its first system for the treatment of vascular thrombosis in 2005. Today, interventional radiologists, cardiologists and vascular surgeons at leading institutions around the world use the EKOS EkoSonic Endovascular System to provide faster, safer and more complete dissolution of thrombus. In 2008, the company introduced its 2nd-generation EkoSonic™ Endovascular System with Rapid Pulse™ Modulation, and in 2009 introduced the MACH4e upgrade. The EkoSonic System is FDA-cleared for controlled and selective infusion of physician-specified fluids, including thrombolytic, into the peripheral vasculature. It is currently used to treat patients with peripheral arterial occlusions (PAO) and deep vein thrombosis (DVT) and additional applications are being investigated. EKOS is currently participating in the ATTRACT trial, which will evaluate the long-term benefits of using ultrasound catheter-directed thrombolysis for removal of clot. Visit www.ekoscorp.com.


News Articles [94 Associated News Articles listed on BioPortfolio]

EKOS™ Control Unit 4.0 Simplifies Treatment of Blood Clots

First commercial units are shipped to Europe BTG plc (LSE: BTG), the global healthcare company, announced today that the first EKOS™ CU 4.0 units have been shipped from BTG...

Bavarian Nordic A/S - Articles of Association

Updated Articles of Association for Bavarian Nordic A/S BavarianNordicArticlesofAssociationThis announcement is distributed by West Corporation on behalf of West Corporation clients.The ...

Ambu A/S: Articles of Association February 2019

Complete Articles of Association February 2019 Complete AoA February 2019This announcement is distributed by West Corporation on behalf of West Corporation clients.The issuer of this announc...

Ambu A/S: Articles of Association November 2018

  Attached the updated Articles of Association November 2018 Complete Articles of Association November 2018This announcement is distributed by West Corporation on behalf of West Corporation...

Ambu A/S: Allan Søgaard Larsen withdraws from Ambu's Board of Directors

Allan Søgaard Larsen, who since 2011 has been a member of the Board in Ambu A/S, has for personal reasons decided to withdraw from the Board with immediate effect. Company_Announcement_no...

Ambu A/S: Articles of Association December 2018

  Attached Complete Articles of Association December 2018 Complete Articles of Association December 2018This announcement is distributed by West Corporation on behalf of West Corporation cl...

Mandatory notification of trade

Valborg Godal Vold, COO of Vistin Pharma ASA, and a primary insider, has on 18 September 2018 sold 50,000 shares in Vistin Pharma ASA at an average price of NOK 10.58 per share. Following this sa...

International Stem Cell Corporation Developed 3D Liver Structures

CARLSBAD, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage bio...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

EkoSonic Endovascular System for patients with acute pulmonary embolism and contraindication to systemic fibrinolysis.

The aim of this study was to evaluate the safety and efficacy of the EkoSonic Endovascular System (EKOS) in patients with acute pulmonary embolism (APE) at high or intermediate-high risk and contraind...

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Submassive Pulmonary Embolism Experience With EKOS

This single site study evaluates the efficacy of ultrasound accelerated thrombolysis using EKOS Endovascular Device with a standard infusion of thrombolytics for treatment of PE

An International Pulmonary Embolism Registry Using EKOS

This registry is designed to understand acoustic pulse thrombolysis (APT) treatment used as standard of care across globally for pulmonary embolism. The registry will include individuals w...

Peripheral Low Dose Thrombolysis Versus Catheter Acoustic Directed Thrombolysis for Submassive PE

To determine whether peripheral low dose systemic thrombolysis (PLST) is non-inferior to catheter directed acoustic pulse thrombolysis (ACDT) in improving RV function and reducing pulmonar...

Interventional Management of Stroke (IMS) III Trial

The purpose of this study is to compare two different treatment approaches—combined intravenous and intra-arterial treatment including recombinant tissue plasminogen activator (rt-PA) an...

Ultrasound Accelerated Catheter-directed Thrombolysis in Primary Ilio-Femoral Deep Venous Thrombosis

Rationale: Iliofemoral deep venous thrombosis (IFDVT) is associated with significant post thrombotic morbidity. The presence of both obstruction and reflux significantly increases the chan...

Companies [179 Associated Companies listed on BioPortfolio]

EKOS Corporation

EKOS Corporation pioneered the development and clinical application of ultrasonic accelerated drug delivery in medicine, introducing its first system for the treatment of vascular...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

Protective Life Corporation

Protective Life Corporation provides financial services through the production, distribution and administration of insurance and investment products throughout the U.S. The compan...

Immusoft Corporation

Immusoft Corporation’s (immusoft.com) mission is to treat diseases using its breakthrough technology platform called Immune System Programming (ISP™). The technology mod...

More Information about "EKOS Corporation" on BioPortfolio

We have published hundreds of EKOS Corporation news stories on BioPortfolio along with dozens of EKOS Corporation Clinical Trials and PubMed Articles about EKOS Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EKOS Corporation Companies in our database. You can also find out about relevant EKOS Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...


Corporate Database Quicklinks



Searches Linking to this Company Record